414 related articles for article (PubMed ID: 15207785)
1. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.
Török HP; Glas J; Tonenchi L; Mussack T; Folwaczny C
Clin Immunol; 2004 Jul; 112(1):85-91. PubMed ID: 15207785
[TBL] [Abstract][Full Text] [Related]
2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
3. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
Franchimont D; Vermeire S; El Housni H; Pierik M; Van Steen K; Gustot T; Quertinmont E; Abramowicz M; Van Gossum A; Devière J; Rutgeerts P
Gut; 2004 Jul; 53(7):987-92. PubMed ID: 15194649
[TBL] [Abstract][Full Text] [Related]
4. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease.
Tal G; Mandelberg A; Dalal I; Cesar K; Somekh E; Tal A; Oron A; Itskovich S; Ballin A; Houri S; Beigelman A; Lider O; Rechavi G; Amariglio N
J Infect Dis; 2004 Jun; 189(11):2057-63. PubMed ID: 15143473
[TBL] [Abstract][Full Text] [Related]
5. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
[TBL] [Abstract][Full Text] [Related]
6. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
7. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
8. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
Wang F; Tahara T; Arisawa T; Shibata T; Nakamura M; Fujita H; Iwata M; Kamiya Y; Nagasaka M; Takahama K; Watanabe M; Hirata I; Nakano H
J Gastroenterol Hepatol; 2007 Jun; 22(6):925-9. PubMed ID: 17565650
[TBL] [Abstract][Full Text] [Related]
10. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings.
Michel O; LeVan TD; Stern D; Dentener M; Thorn J; Gnat D; Beijer ML; Cochaux P; Holt PG; Martinez FD; Rylander R
J Allergy Clin Immunol; 2003 Nov; 112(5):923-9. PubMed ID: 14610481
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
[TBL] [Abstract][Full Text] [Related]
12. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.
Agnese DM; Calvano JE; Hahm SJ; Coyle SM; Corbett SA; Calvano SE; Lowry SF
J Infect Dis; 2002 Nov; 186(10):1522-5. PubMed ID: 12404174
[TBL] [Abstract][Full Text] [Related]
13. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease.
Griga T; Wilkens C; Schmiegel W; Folwaczny C; Hagedorn M; Duerig N; Epplen J; Klein W
Eur J Med Res; 2005 May; 10(5):183-6. PubMed ID: 15946916
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.
Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J
Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678
[TBL] [Abstract][Full Text] [Related]
15. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
[TBL] [Abstract][Full Text] [Related]
16. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.
van der Paardt M; Crusius JB; de Koning MH; Morré SA; van de Stadt RJ; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE
Ann Rheum Dis; 2005 Feb; 64(2):235-8. PubMed ID: 15647432
[TBL] [Abstract][Full Text] [Related]
17. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
[TBL] [Abstract][Full Text] [Related]
18. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
Pierik M; Vermeire S; Steen KV; Joossens S; Claessens G; Vlietinck R; Rutgeerts P
Aliment Pharmacol Ther; 2004 Aug; 20(3):303-10. PubMed ID: 15274667
[TBL] [Abstract][Full Text] [Related]
20. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.
Meena NK; Verma R; Verma N; Ahuja V; Paul J
J Clin Gastroenterol; 2013 Oct; 47(9):773-80. PubMed ID: 23470644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
